Workflow
Solid Biosciences(SLDB)
icon
Search documents
Solid Biosciences(SLDB) - 2018 Q4 - Annual Report
2019-03-13 11:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR Registrant's telephone number, including area code: (617) 337-4680 Securities registered pursuant to Section 12(b) of the Act: Common Stock, $0.001 par value per share The Nasdaq Global Select Market (Title of each class) (Name of each exchange on which registered) Securities register ...
Solid Biosciences (SLDB) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
2019-01-10 20:24
© 2019 Solid Biosciences 1 Solid Biosciences Corporate Overview January 2019 Forward-Looking Statements This presentaDon includes "forward-looking statements" within the meaning of the Private SecuriDes LiDgaDon Reform Act of 1995, which involve a number of risks and uncertainDes. These forward-looking statements include all maOers that are not historical facts and, without limiDng the foregoing, can be idenDfied by the use of forward-looking terminology, including the terms "believe," "esDmate," "project," ...